The transcription factor nuclear factor kappa B (NF-kappa B) rapidly reprograms gene expression in response to various stimuli, and its activity is regulated by several posttranslational modifications, including phosphorylation, methylation, and acetylation. The addition of O-linked beta-N-acetylglucosamine (a process known as O-GlcNAcylation) is an abundant posttranslational modification that is enhanced in conditions such as hyperglycemia and cellular stress. We report that the NF-kappa B subunit c-Rel is modified and activated by O-GlcNAcylation. We identified serine 350 as the site of O-GlcNAcylation, which was required for the DNA binding and transactivation functions of c-Rel. Blocking the O-GlcNAcylation of this residue abrogated c-Rel-mediated expression of the cytokine-encoding genes IL2, IFNG, and CSF2 in response to T cell receptor (TCR) activation, whereas increasing the extent of O-GlcNAcylation of cellular proteins enhanced the expression of these genes. TCR-or tumor necrosis factor (TNF)-induced expression of other NF-kappa B target genes, such as NFKBIA (which encodes I kappa B alpha) and TNFAIP3 (which encodes A20), occurred independently of the O-GlcNAcylation of c-Rel. Our findings suggest a stimulus-specific role for hyperglycemia-induced O-GlcNAcylation of c-Rel in promoting T cell-mediated autoimmunity in conditions such as type 1 diabetes by enhancing the production of T helper cell cytokines.
Activation of the Transcriptional Function of the NF-kappa B Protein c-Rel by O-GlcNAc Glycosylation
Creators
Parameswaran Ramakrishnan - California Institute of Technology
Peter M. Clark - California Institute of Technology
Daniel E. Mason - Genomics Institute of the Novartis Research Foundation
Eric C. Peters - Genomics Institute of the Novartis Research Foundation
Linda C. Hsieh-Wilson - California Institute of Technology
David Baltimore - California Institute of Technology
Publication Details
Science signaling, v 6(290), pp ra75-ra75
Publisher
Amer Assoc Advancement Science
Number of pages
13
Grant note
2R01 GM039458; 2RO1 GM084724 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
R01GM084724 / NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)
Mizutani Foundation for Glycoscience grant
Resource Type
Journal article
Language
English
Academic Unit
School of Biomedical Engineering, Science, and Health Systems; Drexel University
Web of Science ID
WOS:000323707200004
Scopus ID
2-s2.0-84884139186
Other Identifier
991019356498504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: